Made possible by charitable contributions from
Bayer , Astellas / Pfizer , Accuray . Thank You!

Navigation Tip: Click on blue text that’s italicized, underlined and in bold for link to more information.

Greetings!

With the month of August winding down to a close, we hope that you’re doing well as we approach September – Prostate Cancer Awareness Month . It's the perfect time to give a special shout out of appreciation to Dr. Gerald Chodak and Dr. Mark Moyad f or sharing their medical expertise each month in every issue of the Hot SHEET . Thank you, gentlemen!

We’re especially pleased to send you the September 2018 issue of the Hot SHEET newsletter featuring the introduction of Between the Sheets – a new advice column created by experts to help men and women with answers to questions about sexual health and intimacy challenges that can result from prostate cancer treatment. This content is in response to results from a recent survey to support group leaders that identified intimacy and sexual health as underrepresented prostate cancer educational topics.

We’ll feature a special presentation on sex and intimacy relative to prostate cancer, led by Dr. Anne Katz, at the next Prostate Cancer Pathways for Patients and Caregivers in Englewood, NJ, on Saturday, September 29. This free event/webcast will also include presentations from Dr. Charles Drake, Dr. Stacy Loeb, and Dr. Mazyar Ghanaat providing content for managing prostate cancer that’s newly diagnosed, recurring, or advanced. Get more information and register to attend in person, or watch the online webcast with live audio and video from the event. 

We invite you to check out our new web pages on Sexual Health and Intimacy and Incontinence related to prostate cancer treatment. Other recent online educational content developed by Us TOO for the prostate cancer community includes web pages that address Anxiety & Depression , Genetics & Genomic Testing , and Military Veterans/Agent Orange .

By way of additional educational information, we thank prostate cancer survivor Mark Slaughter for his article recapping his experience with chemotherapy in the August 2018 issue of Prostatepedia . Find more disease information on My Prostate Cancer Roadmap , and on cancer.com , a new website with educational content on several types of cancer, including prostate cancer.

We’d also like to call your attention to a variety of support services that includes:


  • The Inspire online prostate cancer community 


  • Support group calls for newly diagnosed and advanced disease in collaboration with Answer Cancer Foundation 



  • LivingWith - a new FREE app for mobile devices to help manage life with cancer  

If you’re in Chicago on Sunday, September 9, join us at the 14th Annual SEA Blue Chicago Prostate Cancer Walk & Run in Lincoln Park. And if you’re in Los Angeles on September 7-9, please visit our booth at the PCRI Prostate Cancer Patient Conference

The Institute for Clinical and Economic Review (ICER) is an independent nonprofit organization that works to assess the clinical effectiveness and value of drugs. ICER has released their draft report on anti-androgen drugs for high-risk prostate cancer that includes enzalutamide (Xtandi®, Astellas and Medivation), abiraterone acetate (Zytiga®, Janssen), and apalutamide (Erleada™, Janssen). CLICK HERE for stakeholder feedback received during the public comment period and corresponding responses from ICER. Stakeholders will have another opportunity to offer verbal comments on the report at a public meeting in Chicago on Thursday, September 13. CLICK HERE to register and follow the directions in order to secure a position during the public comment period. Please participate as it’s important for ICER to hear from members of the prostate cancer community who are impacted by their report. 

Next month we encourage you to raise awareness for prostate cancer by sharing disease facts and statistics in conversations, on social media, or at local festivals, health fairs or events. Let us know if we can assist by providing materials or information.  

Remember that…

“Awareness is the greatest agent for change.” Eckhart Tolle

This is a team effort. We appreciate the dedication and commitment from everyone across the country as we work together to raise awareness for prostate cancer during September and throughout the months that follow – thank you!

All the best, 



Chuck Strand, Chief Executive Officer
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Manager
Amy Woods, Director of Development